C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/22/2001	US20010044412 Gene transfer by forming a complex of an amphiphile binding agent such as a cyclodextrin, an amphiphile, and a polynucleotide, delivering complex to cell and expressing polynucleotide; gene therapy
11/22/2001	US20010044397 Bleaching enzymes and detergent compositions comprising them
11/22/2001	US20010044157 Capillary printing systems
11/22/2001	US20010044151 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/22/2001	US20010044150 Method for transformation of animal cells
11/22/2001	US20010044149 Transfer of heterologous gene sequences into cells using equine infectious anemia virus-derived vectors for gene delivery
11/22/2001	US20010044148 EBV-infected stomach cancer cell line
11/22/2001	US20010044146 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/22/2001	US20010044145 Reduction of genetic expression of RNA target via antisense oligonucleotide
11/22/2001	US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
11/22/2001	US20010044137 Sequence determination using polymerase chain reaction; Vaccinia virus linker
11/22/2001	US20010044136 Precipitating supercoiled plasmid DNA by detergent and redissolving precipitate in salt solution
11/22/2001	US20010044133 Phage-dependent super-production of biologically active protein and peptides
11/22/2001	US20010044132 Spotting target nucleic acid sequence on substrate, hybridizing with sample containing mixture of differently labeled nucleic acids, determining log ratio of signals, normalizing, then calculating anti-log
11/22/2001	US20010044130 G-protein-coupled receptors; receptor binding assay; polypeptides; antibodies; drug screening
11/22/2001	US20010044120 Useful for the prevention or treatment of peptic ulcers in humans or mammals.
11/22/2001	US20010044116 Particulate support bound to at least 2 signal-generating moieties each of which generates, in situ, a signal different from that generated by the other(s); each signal can be varied over a series of gradations
11/22/2001	US20010044115 Biomonomer containing fluid is deposited on a region of a substrate that contains a solid activator and repeating to form the biopolymer; apparatus having the deposition system and processor; computer program
11/22/2001	US20010044114 Chemically assembled nano-scale circuit elements
11/22/2001	US20010044111 Recursively recombing a complex population of DNA fragments, which recombining is homology dependent, to assemble a recombinant DNA molecule
11/22/2001	US20010044109 Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders
11/22/2001	US20010044101 Identifying drug resistant mutant proteins that have been expressed by a library of nucleotide sequences; comparing the relative ultimate clincal efficacies of different drugs targeted against a single protein
11/22/2001	US20010044100 Messenger RNA is used as a target (marker) which exists mainly on float in the cytoplasm and is a transcriptional product of a gene instead of using the translation product.
11/22/2001	US20010043922 Recombinants of the multiply deficient adenoviral vectors; a therapeutic method and their use particularly relating to gene therapy and vaccination
11/22/2001	US20010043921 A retroviral vector of a heterologous nucleic acid sequence as well as at least one sequence allowing site-specific integration of the sequence into a non-coding region of a genome; gene therapy of genetic defects; viricides
11/22/2001	US20010043919 Proliferation of hepatocyte precursors
11/22/2001	US20010043917 Bacteriophage modified by serial passageing or genetic engineering so the modified bacteriophage will remain active in the body for a longer time than the wild-type phage; infections
11/22/2001	DE10032630A1 Vector encoding an expansin, useful in treatment of cellulosic materials for paper recycling, providing large-scale production
11/22/2001	DE10023893A1 New elongase gene extends 16, 18 and 20 carbon fatty acids, useful to manipulate plants to produce polyunsaturated fatty acids for the foodstuffs, cosmetics and pharmaceutical industries
11/22/2001	DE10009119A1 Vertebraten Globin Vertebrate globin
11/22/2001	CA2410181A1 Novel motor proteins and methods for their use
11/22/2001	CA2410056A1 Induction of apoptosis and cell growth inhibition by protein 4.33
11/22/2001	CA2410028A1 Ligands specific for an isoform of the prion protein
11/22/2001	CA2409752A1 Single copy genomic hybridization probes and method of generating same
11/22/2001	CA2409746A1 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	CA2409701A1 Method for introducing a nucleic acid into a cell (transfection) by means of calcium phosphate, and transfected cell
11/22/2001	CA2409506A1 Method for cell adhesion and wound healing
11/22/2001	CA2409448A1 Methods for modulating the proliferation of hematopoietic cells
11/22/2001	CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	CA2409361A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	CA2409172A1 Plant gene targeting using oligonucleotides
11/22/2001	CA2409154A1 Compositions, kits, and methods for identification and modulation of t helper-1 and t helper-2 cells and diseases associated therewith
11/22/2001	CA2409148A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	CA2409075A1 Model for neurodegenerative disease
11/22/2001	CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001	CA2409050A1 Insect resistant transgenic plants expressing biotin-binding protein gene
11/22/2001	CA2409031A1 Insecticidal secreted proteins of brevibacillus laterosporus
11/22/2001	CA2408891A1 Separation device
11/22/2001	CA2408885A1 Vectors for dna delivery
11/22/2001	CA2408830A1 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	CA2408827A1 Novel human lipocalin homologs and polynucleotides encoding the same
11/22/2001	CA2408756A1 Immune potentiating compositions
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408701A1 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001	CA2408691A1 Compositions and methods for achieving immune suppression
11/22/2001	CA2408617A1 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	CA2408530A1 Novel deoxynucleoside kinase enzyme variants
11/22/2001	CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	CA2408503A1 Seven transmembrane proteins and polynucleotides encoding the same
11/22/2001	CA2408433A1 Synthetic gagpol genes and their uses
11/22/2001	CA2408403A1 Vaccines, immunotherapeutics and methods for using the same
11/22/2001	CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001	CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2408246A1 Cell line for the expression of an .alpha.2.delta.2 calcium channel subunit
11/22/2001	CA2408134A1 G-protein coupled receptors
11/22/2001	CA2408060A1 Directed evolution of oxidase enzymes
11/22/2001	CA2407707A1 In vitro fucosylation recombinant glycopeptides
11/22/2001	CA2407259A1 Polyketide derivatives
11/22/2001	CA2398979A1 Novel bee venom polypeptides and methods of use thereof
11/22/2001	CA2375082A1 Sequence based screening
11/22/2001	CA2374969A1 Transformant and process for producing polyester by using the same
11/21/2001	EP1156334A2 Method for screening a substance having promoting activity on hair growth
11/21/2001	EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction
11/21/2001	EP1156122A2 A fluorescence polarization assay method
11/21/2001	EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response
11/21/2001	EP1156118A1 Virus vector
11/21/2001	EP1156117A2 Methods for isolating modulators of carotenoid biosynthesis enzymes
11/21/2001	EP1156116A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defense
11/21/2001	EP1156115A1 Corynebacterium glutamicum strain with enhanced secretion activity
11/21/2001	EP1156114A1 Vectors for use in transponson-based DNA sequencing methods
11/21/2001	EP1156113A1 Corynebacterium glutamicum expressing heterologous amylase
11/21/2001	EP1156112A1 Synthetic gagpol genes and their uses
11/21/2001	EP1156111A1 Chimeric arterivirus-like particles
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156109A1 MYC targets
11/21/2001	EP1156108A2 Use of exo-sample nucleotides in gene cloning
11/21/2001	EP1156107A1 Method for analyzing gene expression frequency
11/21/2001	EP1156106A1 Novel enzyme having decoloring activity and method for decoloring dyes by using the same
11/21/2001	EP1156104A1 A-agarase and process for producing the same
11/21/2001	EP1156103A2 Oplophorus luciferase
11/21/2001	EP1156102A1 Immunodeficiency virus recombinant poxvirus vaccine
11/21/2001	EP1156064A2 Cat-mouse chimeric antibody directed to feline diseases and corresponding heterohydridoma
11/21/2001	EP1156061A1 Reagent for the diagnosis of rheumatoid arthritis
11/21/2001	EP1155736A2 Solution and process for producing biochip
11/21/2001	EP1155700A2 Lymphocyte chemoattractant factor and uses thereof
11/21/2001	EP1155379A1 Determining protein function and interaction from genome analysis
11/21/2001	EP1155361A2 Methods to reduce variance in treatment studies using genotyping

1 ... 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 2957 2958 ... 4023